cache/3b168bac48d99b8b07ce69ec727bc25b9b90309dd92719a12c14c9b90dc72298

COM:MED-TECHEXPO

Med-Tech Innovation Expo

  • Privately Held

Company Overview

Metric
Company NameMed-Tech Innovation Expo3Azenta, Inc.BioInteractions
SymbolMMMAZTA
MSH IDCOM:MED-TECHEXPOCOM:3MCOM:AZENTACOM:BIOINTERACTIONS
MarketPRIVATESTOCKSSTOCKSPRIVATE
SectorCommercial & Professional ServicesIndustrialsHealthcareHealthcare & Health Services
IndustryMedical Device ManufacturingConglomeratesMedical - Instruments & SuppliesBiotechnology
CountryGBUSUSGB
Stage
Employee Count85K3.40K
Websitemed-techexpo.com3m.comazenta.combiointeractions.com
LinkedInmed-tech-innovationbiointeractions-ltd
Founders

Market Metrics

Metric
Market Cap56.26B2.72B
Enterprise Value
Monthly Web Traffic3.49M
Web Traffic Growth-0.06
Valuation
Raised Capital

Financial Performance

Metric
Revenue32.68B665.07M
Revenue (LTM)
Revenue (NTM)
Gross Profit14.20B263.14M
EBITDA-9.13B41.18M
Operating Income-9.13B-73.13M
Net Income-7.00B-14.26M
EPS-12.63-0.22
Diluted EPS-12.63-0.22
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.440.39
Operating Profit Margin0.04-0.11
EBITDA Margin-0.280.06
Net Profit Margin0.03-0.02
Return on Equity0.21-0.01
Return on Assets0.02-0.01
Return on Capital Employed0.05-0.03

Valuation Multiples

Metric
P/E Ratio-7.36-346.32
P/B Ratio10.581.55
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio2.475.25
EV Multiple25.57455.78

Operational Metrics

Metric
Days Sales Outstanding53.0585.91
Days Payables Outstanding64.1032.51
Days Inventory Outstanding98.25118.96
Operating Cycle151.34217.62
Cash Conversion Cycle85.48183.35
Asset Turnover0.710.28

Cash Flow Metrics

Metric
Operating Cash Flow6.68B17.49M
Free Cash Flow5.07B-21.95M
Cash Flow to Debt0.431.23
Operating Cash Flow/Sales0.200.14
Free Cash Flow Yield0.11-0.01

Balance Sheet Metrics

Metric
Cash & Equivalents310.93M
Accounts Receivable-170M33.99M
Inventory115.26M
Goodwill691.41M
Debt to Capitalization0.820.03
Debt to Assets0.320.02
Current Ratio1.076.73
Quick Ratio1.275.26

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.010.01
R&D to Revenue0.060.05
SG&A to Revenue0.61